Ligases Enzyme Industry Expansion Forecast Showing Market Size of $6.34 Billion by 2030 at 12.3% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Ligases Enzyme Market Over The Period 2026–2030?
The ligases enzyme market has experienced rapid growth in recent years. It is projected to expand from $3.57 billion in 2025 to $3.99 billion in 2026, showing a compound annual growth rate (CAGR) of 11.7%. The market’s historical expansion is attributable to increased molecular biology research, the early integration of ligase enzymes in cloning, the proliferation of academic research laboratories, heightened pharmaceutical R&D endeavors, and the growing application of enzymatic tools in diagnostics.
The ligases enzyme market is poised for significant expansion over the coming years. Its valuation is projected to reach $6.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This anticipated growth during the forecast period stems from factors such as heightened demand for advanced genetic testing, the broadening of next-generation sequencing applications, increasing investments within biotechnology research, a stronger emphasis on personalized medicine, and the growing uptake of ligase-based diagnostic techniques. Key trends observed within the forecast period encompass a surging demand for these enzymes in molecular cloning, the expanding utilization of ligases in genetic research, their increased incorporation into diagnostic assays, the widening scope of ligase applications in drug discovery, and a growing inclination towards high-efficiency and specialized ligases.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12226&type=smp
Which Economic Or Industry Drivers Are Impacting The Ligases Enzyme Market?
The growing prevalence of cancer and genetic disorders is anticipated to propel the expansion of the ligase’s enzyme market moving forward. Cancer denotes a collection of illnesses characterized by the unrestrained proliferation and dissemination of abnormal cells, while genetic disorders represent a broad spectrum of medical conditions caused by irregularities or mutations in an individual’s genetic material, specifically their DNA. Ligase enzymes are fundamental for DNA replication, repair, and recombination. In cancer, ligases can contribute to repairing damaged DNA, thereby fostering the unchecked growth of cells. These enzymes can also be utilized to target and eliminate cells afflicted with genetic disorders. For illustration, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, showed that the number of cancer cases diagnosed in Australia rose from 160,570 in 2022 to 164,694 in 2023, indicating a notable increase over the year. This ascending trend underscores the rising incidence of cancer within the nation. Additionally, 403 new cancer cases and 144 cancer-related deaths were documented for every 100,000 people. Furthermore, in February 2023, Gene People UK, a UK-based registered charity group, reported that approximately 1 in 25 children in the UK are affected by a genetic condition, resulting in more than 2.4 million children and adults in the UK living with a genetic disorder, with 30,000 babies and children newly diagnosed each year. Consequently, the increasing prevalence of cancer and genetic disorders is a key driver for the growth of the ligase’s enzyme market. An escalation in research and development (R&D) activities is projected to fuel the growth of the ligase enzyme market in the upcoming period. Research and development activities encompass the investigative work undertaken by a company or organization to enhance existing products and procedures or to facilitate the creation of new ones. Ligase enzymes, also identified as DNA ligases, perform a critical function in joining DNA molecules, rendering them indispensable tools for diverse R&D initiatives across various fields. For example, in February 2025, a report issued by the National Science Foundation (NSF), a U.S.-based federal agency, indicated that total research and experimental development (R&D) expenditures in the United States amounted to $892 billion in 2022, with an estimated increase to $940 billion in 2023. Hence, the surge in research and development activities is propelling the expansion of the ligase enzyme market.
How Is The Ligases Enzyme Market Divided Into Its Major Segments?
The ligases enzyme market covered in this report is segmented –
1) By Type: E. coli DNA Ligases, T4 DNA Ligase, Mammalian Ligases, Thermostable Ligases
2) By Source: Microorganisms, Animal
3) By Application: Ligase Chain Reaction (LCR), Ligase Detection Reaction (LDR), Next-Generation Sequencing (NGS), Rolling Circle Amplification (RCA), Proximity Ligation Assay (PLA), Molecular Cloning, Ligation Mediated PCR, Mutation Detection
4) By End-User: Research Laboratories And Institutions, Pharmaceutical And Biopharmaceutical Companies, Diagnostic Laboratories
Subsegments:
1) By E. coli DNA Ligase: Ligase I, Ligase II
2) By T4 DNA Ligase: Wild-Type T4 Ligase, Modified T4 Ligase
3) By Mammalian Ligases: Ligase IV, Ligase I
4) By Thermostable Ligases: Taq DNA Ligase, Pyrococcus Furiosus Ligase
What Trends Are Affecting The Expansion Of The Ligases Enzyme Market?
Leading firms within the ligases enzyme market are focused on evolving methods, including nanopore technologies, to boost the accuracy and effectiveness of DNA sequencing and manipulation, consequently advancing uses in genomics, synthetic biology, and personalized medicine. These nanopore technologies function by employing tiny pores to identify and examine molecules, like DNA or proteins, through monitoring variations in the ionic current as these substances move through the pore. An illustration of this is how, in February 2023, Eurofins Genomics, a US-based biotechnology company, introduced its Express Oxford Nanopore Sequencing service. This service leverages Oxford Nanopore technology, enabling the sequencing of extended DNA fragments. Such capability proves especially valuable for tasks demanding thorough genomic examination, including metagenomics and the identification of structural variants.
Who Are The Prominent Organizations Shaping The Ligases Enzyme Market?
Major companies operating in the ligases enzyme market are New England Biolabs Inc., Promega Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Creative Enzymes, ArcticZymes Technologies ASA, BLIRT S.A., Jena Bioscience, Enzo Life Sciences, BioVision Inc., Bioneer Corporation, Sino Biological Inc., Genetix Biotech Asia Pvt. Ltd., Omega Bio-tek Inc., Canvax Biotech, NZYGene, Vivantis Technologies, Toyobo Co. Ltd.
Read the full ligases enzyme market report here:
https://www.thebusinessresearchcompany.com/report/ligases-enzyme-global-market-report
What Are The Top-Performing Regions Within The Ligases Enzyme Market?
North America was the largest region in the ligases enzyme market in 2025. Asia-Pacific is expected to be the fastest-growing region in the ligases enzyme market report during the forecast period. The regions covered in the ligases enzyme market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Ligases Enzyme Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12226&type=smp
Browse Through More Reports Similar to the Global Ligases Enzyme Market 2026, By The Business Research Company
Enzyme Global Market Report
https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report
Industrial Enzymes Global Market Report
https://www.thebusinessresearchcompany.com/report/industrial-enzymes-global-market-report
Food Enzymes Global Market Report
https://www.thebusinessresearchcompany.com/report/food-enzymes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
